wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38167808-ECEC4F25-D308-4FBE-8223-66538A352EC3
Q38167808-ECEC4F25-D308-4FBE-8223-66538A352EC3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38167808-ECEC4F25-D308-4FBE-8223-66538A352EC3
Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer.
P2860
Q38167808-ECEC4F25-D308-4FBE-8223-66538A352EC3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38167808-ECEC4F25-D308-4FBE-8223-66538A352EC3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3e39e9ab534a71d462fc3f883d7aab53ba426128
P2860
Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice.